Pioneering sound-wave vibration–frequency digital therapy designed to support neural pathway modulation and enhance emotional and cognitive regulation.

We have built one of the world’s most advanced human voice biomarker libraries and developed AI-driven neural-model inversion methods. Based on these foundations, we created an integrated framework that includes an individualized voice-biomarker modeling system, a neural pathway prediction model, an audio-synthesis intervention engine, and a full-process closed-loop regulation system.

This framework enables a quantifiable, reversible, and monitorable stimulation pathway that supports targeted neuromodulation. As one of the few organizations globally to construct a closed-loop “neuro–audio–data” tri-element architecture, our acoustic neuromodulation mechanism is designed to act on specific neural pathways and generate what we call a Digital Acoustic Capsule—a personalized sound-based modulation unit tailored to an individual’s neural profile.

Unlike traditional music therapy or general psychological soothing methods, our intervention mechanism is grounded in a neurophysiological model and is designed to act on specific neural pathways within the brain. By analyzing individualized human voice markers, we derive controllable neural circuits that guide the generation of personalized sound-wave vibration-frequency parameters.

These parameters are then synthesized into precisely targeted audio signals that are fed back to the user as a form of neural-system modulation. We refer to this personalized, algorithm-driven modulation unit as the Acoustic Digital Capsule

We have independently developed a comprehensive, closed-loop technical framework grounded in human voice biomarkers. This framework integrates data collection, analysis, individualized modeling, personalized audio synthesis, and physical acoustic intervention. Through proprietary algorithms, the system generates personalized vibration-frequency signals designed to support real-time neuromodulation.

The solution is delivered through a mobile application that ensures high accessibility, convenience, and full traceability of intervention records. We are actively advancing the regulatory approval process for digital medical products and aim to establish one of the first registered acoustic-intervention medical devices in the field of neurotechnology.

Our research on the relationship between speech frequency and neural responses has enabled the development of a key parameter model of the brain’s neural conduction mechanisms. This model simulates neural response pathways and identifies potential intervention points, forming the foundational technology for our acoustic intervention system to deliver precise, targeted stimulation and efficient feedback.

In collaboration with Pengcheng Laboratory, we are integrating phasor databases, video compression, and privacy-preserving technologies to develop a high-speed, high-security computing platform. This system supports ultra-large-scale voiceprint data training and cross-regional modeling, establishing a robust foundation for large-scale AI-driven mental health services.

We have advanced beyond traditional auditory pathways to develop high-penetration bone-conduction vibration frequency technology, enabling non-aural delivery of sound waves through the skull and nervous system. This approach effectively enhances neural response efficiency in deep brain circuits, offering more effective physical intervention options for targeted populations, such as children with autism or individuals with neurological delays.

We are the first to propose a voiceprint marker system for newborns and children, establishing a database that tracks individual psychological development. This system enables early detection of developmental abnormalities and provides a scientific foundation for personalized education and interventions, ensuring every child’s brain health is safeguarded.

JingBell’s audio neuromodulation system has been applied across multiple domains

Our audio neuromodulation systems are applied across child development, mental health, cognitive decline, rehabilitation medicine, and insurance-based health screening, delivering personalized interventions while redefining healthcare practices. Looking forward, we aim to expand clinical applications, drive scientific breakthroughs, and foster international collaborations, positioning China at the forefront of digital neuroregulation.